Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q2 2024 Earnings

2MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.9

-0.68

-0.47

-0.25

Details

Expected EPS

-0.720593

Actual EPS

-0.69

Surprise EPS

0.03

Surprise Percent

+4.25%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.69 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.